Breast cancer and depot-medroxyprogesterone acetate: a multinational study: WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES
- 5 October 1991
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 338 (8771) , 833-838
- https://doi.org/10.1016/0140-6736(91)91498-j
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Breast cancer and combined oral contraceptives: results from a multinational studyBritish Journal of Cancer, 1990
- Oral contraceptive use influences resting breast proliferationHuman Pathology, 1989
- Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer.BMJ, 1989
- The effect of age and menstrual cycle upon proliferative activity of the normal human breastBritish Journal of Cancer, 1988
- Oral-Contraceptive Use and the Risk of Breast CancerNew England Journal of Medicine, 1986
- A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual CycleThe American Journal of Surgical Pathology, 1986
- Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injectionsJAMA, 1983
- The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?Published by American Medical Association (AMA) ,1983
- NONESTROGENIC DRUGS AND BREAST CANCERAmerican Journal of Epidemiology, 1982
- The association of depo-medroxyprogesterone acetate and breast cancerContraception, 1980